498 related articles for article (PubMed ID: 18286380)
1. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
2. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
3. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
Morrell S; Taylor R; Wain G
J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
[TBL] [Abstract][Full Text] [Related]
4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
6. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
8. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
[TBL] [Abstract][Full Text] [Related]
9. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
10. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
11. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
13. Correlates of intent to seek unnecessary pap tests among elderly women.
Zhang Y; Borders TF; Rohrer JE
Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
[TBL] [Abstract][Full Text] [Related]
14. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
15. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
Mitchell H; Hocking J; Saville M
Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
[TBL] [Abstract][Full Text] [Related]
16. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
[TBL] [Abstract][Full Text] [Related]
17. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
18. Determinants of the geographic variation of invasive cervical cancer in Costa Rica.
Herrero R; Brinton LA; Hartge P; Reeves WC; Breñes MM; Urcuyo R; Pacheco M; Fuster F; Sierra R
Bull Pan Am Health Organ; 1993; 27(1):15-25. PubMed ID: 8490673
[TBL] [Abstract][Full Text] [Related]
19. Hispanic acculturation and utilization of cervical cancer screening in the US.
Shah M; Zhu K; Wu H; Potter J
Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
[TBL] [Abstract][Full Text] [Related]
20. Use of the Pap test by a population group in Buenos Aires.
Klimovsky E; Matos E
Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
